Akhavan Hamid 4
4 · EchoStar CORP · Filed Jun 9, 2026
Research Summary
AI-generated summary of this filing
EchoStar (SATS) CEO Hamid Akhavan Exercises Options, Sells Shares
What Happened
Hamid Akhavan, CEO and director of EchoStar (SATS) and head of EchoStar Capital, exercised stock options on June 5, 2026 and sold a portion of the resulting shares the same day. He exercised options to acquire 142,917 shares at $14.04 per share (total exercise cost ≈ $2,006,555) and sold 52,586 shares in open-market transactions at $121.00 per share (total proceeds ≈ $6,362,906). The filing also records corresponding derivative disposals reflecting the removal of the exercised option positions.
Key Details
- Transaction date: June 5, 2026; Form 4 filed June 9, 2026 (timely filed).
- Exercise price: $14.04 per share (options exercised for ~142,917 shares; aggregate exercise cost ≈ $2.01M).
- Open-market sale price: $121.00 per share (52,586 shares sold; proceeds ≈ $6.36M).
- Shares owned after the transactions: not specified in the provided filing extract.
- Trading plan / restrictions: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted March 6, 2026 (Footnote F1).
- Other footnotes: F2 references 401(k) treatment; F3/F4 describe vesting schedules for the options (one grant: 40% immediate vesting then remaining 60% vesting 30% per year on 4/1/2025 and 4/1/2026; another grant vests 25% per year on 4/1/2025–4/1/2028).
- Derivative entries: the filing shows both acquisitions (exercises) and corresponding derivative disposals, which is standard bookkeeping when options are exercised.
Context
- The pattern (exercise at $14.04 and same-day market sales at $121) indicates Akhavan converted options into shares and monetized a portion of them; this is commonly a cashless or partial monetization of option value.
- Sales were carried out under a pre-established 10b5-1 plan, which is intended to establish trading parameters in advance and reduce questions about timing.
- As always, insider sales can be routine (liquidity/tax reasons); these transactions are factual disclosures and do not by themselves indicate management’s view of the company’s prospects.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
[F1]2026-06-05$14.04/sh+122,500$1,719,900→ 910,706 total - Sale
Class A Common Stock
[F1]2026-06-05$121.00/sh−45,073$5,453,833→ 865,633 total - Exercise/Conversion
Class A Common Stock
[F1]2026-06-05$14.04/sh+20,417$286,655→ 886,050 total - Sale
Class A Common Stock
[F1]2026-06-05$121.00/sh−7,513$909,073→ 878,537 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F1][F3]2026-06-05$14.04/sh−122,500$1,719,900→ 0 totalExercise: $14.04Exp: 2034-04-01→ Class A Common Stock (122,500 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F1][F4]2026-06-05$14.04/sh−20,417$286,655→ 40,834 totalExercise: $14.04Exp: 2034-04-01→ Class A Common Stock (20,417 underlying)
- 364(indirect: I)
Class A Common Stock
[F2]
Footnotes (4)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
- [F2]By 401(K).
- [F3]40% of the shares underlying these options vested immediately upon the grant date. The remaining 60% of the shares underlying these options vest 30% per year on each of April 1, 2025 and April 1, 2026.
- [F4]The shares underlying these options vest 25% per year on each of April 1, 2025, April 1, 2026, April 1, 2027 and April 1, 2028.